dasatinib bm fdaapprov multitarget kind inhibitor crab src kind use treatment chronic myelogen leukemia col resist inter prior therapy include imatinib report novel effect induce different act myeloid aml cell mekerkdepend active signal transduc active transcript stat found could induce demons express marker cdb gg phase arrest decrease ratio nucleus cytoplasm note induce robust phosphorus try ser well redistributed thu lead stattarget gene knock sha significantly attend dasatinibinduc india import role mater regal meters phosporyl mek era occur rapidly upon increase progress inhibitor pd u inhibit also blog suggest depend might indispens different taken together studi suggest media whose require cascade 